Literature DB >> 10201740

Interaction between fibronectin and eosinophils in the growth of nasal polyps.

T Nakagawa1, H Yamane, T Shigeta, T Takashima, Y Nakai.   

Abstract

OBJECTIVES: The aim of this study was to determine roles of fibronectin and eosinophils in the etiology of nasal polyposis. STUDY
DESIGN: We designed a cohort study of cases with nasal polyposis. Sampled nasal polyps were differentiated by their histopathologic characteristics, and compared by size and computed tomography (CT) stage.
METHODS: The size of nasal polyps was determined on the basis of the endoscopic findings, and the extent of sinusitis was evaluated by CT staging. Nasal polyp samples were taken from 82 patients during ethmoidectomy and differentiated by morphologic characteristics, infiltration cell types, or fibronectin positivity. Then their sizes and CT stages were compared. In addition, correlation among these histological characteristics was analyzed.
RESULTS: Nasal polyps showing edematous morphology, eosinophil infiltration, or fibronectin expression were significantly large in size. Concerning CT stages, only the infiltration cell type showed a significant difference. Significant correlation among edematous morphology, eosinophil infiltration, and fibronectin expression was also recognized.
CONCLUSIONS: These findings suggest that interaction between eosinophils and fibronectin may play a role in edema formation, which contributes to the growth of nasal polyps.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10201740     DOI: 10.1097/00005537-199904000-00007

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

Review 1.  Damage-associated molecular patterns and their receptors in upper airway pathologies.

Authors:  Koen Van Crombruggen; Fenila Jacob; Nan Zhang; Claus Bachert
Journal:  Cell Mol Life Sci       Date:  2013-05-15       Impact factor: 9.261

Review 2.  Pathophysiology of chronic rhinosinusitis, pharmaceutical therapy options.

Authors:  Claus Bachert; Gabriële Holtappels
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

3.  Effect Of Bevacizumab On Growth Of Human Nasal Polyposis In Vitro; An Off-Label Use Of Anti-Angiogenic Agent For Nasal Polyposis Treatment.

Authors:  Shadman Nemati; Faeze Keihanian; Amin Saeidinia; Mahdi Bakhshaei
Journal:  Drug Des Devel Ther       Date:  2019-09-24       Impact factor: 4.162

4.  The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling.

Authors:  Juan Meng; Peng Zhou; Yafeng Liu; Feng Liu; Xuelian Yi; Shixi Liu; Gabriele Holtappels; Claus Bachert; Nan Zhang
Journal:  PLoS One       Date:  2013-12-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.